Subscribe to Breaking News emails
You have successfully subscribed to the Breaking News email.
Subscribe today to be the first to to know about breaking news and special reports.
FDA approves first at-home genetic test to assess breast cancer risk
The kit from the company 23andMe tests for three mutations and is available without a prescription — though the test has limitations and it is recommended that the results are confirmed with a doctor.
Video captures Indiana school bus driver allowing kids to drive vehicle01:14
New device helps paralyzed patients walk again01:12
Congress could require FAA to set minimum legroom and seat size standards01:07
Rob Goldstone gives revealing look inside Mueller grand jury room02:10
Dallas police department fires officer after manslaughter charges00:56
Bill Cosby sentencing trial begins01:15